Passage Bio, Inc. (PASG) vs Tempest Therapeutics, Inc. (TPST)
A side-by-side comparison of Passage Bio, Inc. and Tempest Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PASG
Passage Bio, Inc.
$4.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TPST
Tempest Therapeutics, Inc.
$0.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PASG vs TPST
growth of $100 · dividends reinvested · last 7yPASG -99.1% (-48.8%/yr)TPST -100.0% (-66.5%/yr)PASG compounded faster over this window
Log scale — wide-divergence pair
PASG TPST
PASG vs TPST: by the numbers
- •PASG is the larger company ($13M vs $13M market cap).
Metrics side by side
Valuation
| Metric | PASG | TPST |
|---|---|---|
| P/B ratio | 2.94 | N/A |
Profitability
| Metric | PASG | TPST |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -810.41% | N/A |
| ROIC | -889.92% | -784.16% |
Growth (annualized)
| Metric | PASG | TPST |
|---|---|---|
| Total return CAGR (5Y) | -53.23% | -66.75% |
Frequently asked
- How have PASG and TPST total returns compared?
- Over the past 5 years, PASG delivered -53.23% and TPST delivered -66.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.